97 related articles for article (PubMed ID: 5458710)
1. [Fluphenazine oenanthate ("Moditen-Retard" N.D.) chemistry and pharmacology].
Viala A
Encephale; 1970; ():Suppl:3-9. PubMed ID: 5458710
[No Abstract] [Full Text] [Related]
2. [Secondary effects of Moditen-Retard].
Fouks L
Encephale; 1970; ():Suppl:14-8. PubMed ID: 5458708
[No Abstract] [Full Text] [Related]
3. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
Haumonté MT; Hoerdt HP
Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
[No Abstract] [Full Text] [Related]
4. [Fluphenazine oenanthate in post-hospital treatment].
Lambert PA; Marcou G
Encephale; 1970; ():Suppl:26-32. PubMed ID: 4318811
[No Abstract] [Full Text] [Related]
5. [Use of fluphenazine oenanthate in psychiatric therapy (personal experience)].
Darcourt G; Lavagna J; Myquel M; Bècle J
Ann Med Psychol (Paris); 1971 Oct; 2(3):448-59. PubMed ID: 5128638
[No Abstract] [Full Text] [Related]
6. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
Jouen F; Verité P; André D; Colonna L; Boucly P
Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic effect of protracted neuroleptics, fluphenazine oenanthate and oxyprothepine oenanthate (VUFB 9447)].
Votava Z; Dlabac A; Kazdová E; Likovský Z
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():187-98. PubMed ID: 22886
[TBL] [Abstract][Full Text] [Related]
8. [Advantages and indications of Moditen-Retard].
Vallade L
Encephale; 1970; ():Suppl:10-3. PubMed ID: 5458707
[No Abstract] [Full Text] [Related]
9. [Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)].
Delay J; Deniker P; Perier M; Dalle B
Presse Med (1893); 1967 May; 75(24):1243-6. PubMed ID: 6024177
[No Abstract] [Full Text] [Related]
10. [New perspectives offered by an injectable delayed-action neuroleptic: fluphenazine enanthate].
Lambert PA; Midenet M; Midenet J; Marcou G; Bouchardy M
Ann Med Psychol (Paris); 1966 May; 124(5):702-7. PubMed ID: 5941462
[No Abstract] [Full Text] [Related]
11. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
Moldenhauer B
Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
[No Abstract] [Full Text] [Related]
12. [Importance of delayed-action neuroleptics].
Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
Ann Med Psychol (Paris); 1969 May; 1(5):772-8. PubMed ID: 5398062
[No Abstract] [Full Text] [Related]
13. [Importance of delayed-action neuroleptics].
Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
Ann Med Psychol (Paris); 1969 May; 127(5):772-8. PubMed ID: 5397523
[No Abstract] [Full Text] [Related]
14. Metabolic studies with long-acting compounds.
Schreiber EC; Grozier ML
Therapie; 1973; 28(3):441-58. PubMed ID: 4771900
[No Abstract] [Full Text] [Related]
15. [Study of the use and therapeutic activity of oenanthate of fluphenazine, a neuroleptic with long-term action, in psychoses in children].
Michaux L; Dugas M; Colomb G; Guériot C
Rev Neuropsychiatr Infant; 1971 Jun; 19(6):351-9. PubMed ID: 5564560
[No Abstract] [Full Text] [Related]
16. The pharmacology and therapeutic application of the phenothiazines.
Rivera-Calimlim L
Ration Drug Ther; 1977 Apr; 11(4):1-8. PubMed ID: 16316
[No Abstract] [Full Text] [Related]
17. [Adverse effects of long-acting fluphenazine].
Lievre JA; Guillien P; Boccara M
Presse Med (1893); 1971 Sep; 79(40):1757. PubMed ID: 5120822
[No Abstract] [Full Text] [Related]
18. [Implications of delayed-action drugs].
Biéder J
Ann Med Psychol (Paris); 1970 Oct; 2(3):424-7. PubMed ID: 5481457
[No Abstract] [Full Text] [Related]
19. Study of accumulation of fluphenazine enanthate and fluphenazine decanoate, long-acting neuroleptic drugs, after repeated administrations by means of their inhibitory effects on the discriminated avoidance response in rats.
Kuribara H; Tadokoro S
J Toxicol Sci; 1979 May; 4(2):87-98. PubMed ID: 501762
[No Abstract] [Full Text] [Related]
20. [Therapeutic management, the hospital environment].
Gayral L
Encephale; 1970; ():Suppl:19-25. PubMed ID: 5458709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
